These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29876019)

  • 21. Impact of skeletal muscle mass on complications following expander breast reconstruction.
    Nakamura H; Makiguchi T; Yamaguchi T; Fujii T; Shirabe K; Yokoo S
    J Plast Reconstr Aesthet Surg; 2020 Jul; 73(7):1285-1291. PubMed ID: 32201325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting.
    Psutka SP; Boorjian SA; Moynagh MR; Schmit GD; Frank I; Carrasco A; Stewart SB; Tarrell R; Thapa P; Tollefson MK
    J Urol; 2015 May; 193(5):1507-13. PubMed ID: 25464002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy.
    Jung HW; Kim JW; Kim JY; Kim SW; Yang HK; Lee JW; Lee KW; Kim DW; Kang SB; Kim KI; Kim CH; Kim JH
    Support Care Cancer; 2015 Mar; 23(3):687-94. PubMed ID: 25163434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients.
    Basile D; Parnofiello A; Vitale MG; Cortiula F; Gerratana L; Fanotto V; Lisanti C; Pelizzari G; Ongaro E; Bartoletti M; Garattini SK; Andreotti VJ; Bacco A; Iacono D; Bonotto M; Casagrande M; Ermacora P; Puglisi F; Pella N; Fasola G; Aprile G; Cardellino GG
    J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):368-377. PubMed ID: 30719874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of sarcopenia in older patients with colorectal cancer.
    Broughman JR; Williams GR; Deal AM; Yu H; Nyrop KA; Alston SM; Gordon BB; Sanoff HK; Muss HB
    J Geriatr Oncol; 2015 Nov; 6(6):442-5. PubMed ID: 26365898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond sarcopenia: Characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population.
    Weinberg MS; Shachar SS; Muss HB; Deal AM; Popuri K; Yu H; Nyrop KA; Alston SM; Williams GR
    Breast J; 2018 May; 24(3):278-284. PubMed ID: 29139618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.
    da Rocha IMG; Marcadenti A; de Medeiros GOC; Bezerra RA; Rego JFM; Gonzalez MC; Fayh APT
    J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):445-454. PubMed ID: 30924270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Roberto M; Barchiesi G; Resuli B; Verrico M; Speranza I; Cristofani L; Pediconi F; Tomao F; Botticelli A; Santini D
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339347
    [No Abstract]   [Full Text] [Related]  

  • 29. Sarcopenia as a predictor of poor surgical and oncologic outcomes after abdominal surgery for digestive tract cancer: A prospective cohort study.
    Zhang S; Tan S; Jiang Y; Xi Q; Meng Q; Zhuang Q; Han Y; Sui X; Wu G
    Clin Nutr; 2019 Dec; 38(6):2881-2888. PubMed ID: 30630709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of sarcopenia status of muscle-invasive bladder cancer patients on kidney function after neoadjuvant chemotherapy.
    Regnier P; DE Luca V; Brunelle S; Sfumato P; Walz J; Rybikowski S; Maubon T; Branger N; Fakhfakh S; Durand M; Gravis G; Pignot G
    Minerva Urol Nephrol; 2021 Apr; 73(2):215-224. PubMed ID: 32083413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of sarcopenia in patients with respiratory failure classified as normally nourished using computed tomography and subjective global assessment.
    Sheean PM; Peterson SJ; Gomez Perez S; Troy KL; Patel A; Sclamberg JS; Ajanaku FC; Braunschweig CA
    JPEN J Parenter Enteral Nutr; 2014 Sep; 38(7):873-9. PubMed ID: 23980135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases.
    Eriksson S; Nilsson JH; Strandberg Holka P; Eberhard J; Keussen I; Sturesson C
    HPB (Oxford); 2017 Apr; 19(4):331-337. PubMed ID: 28089364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.
    Huang CY; Yang YC; Chen TC; Chen JR; Chen YJ; Wu MH; Jan YT; Chang CL; Lee J
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):534-546. PubMed ID: 31999069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
    Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma.
    Antoun S; Baracos VE; Birdsell L; Escudier B; Sawyer MB
    Ann Oncol; 2010 Aug; 21(8):1594-1598. PubMed ID: 20089558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer.
    Wendrich AW; Swartz JE; Bril SI; Wegner I; de Graeff A; Smid EJ; de Bree R; Pothen AJ
    Oral Oncol; 2017 Aug; 71():26-33. PubMed ID: 28688687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle wasting associated with the long-term use of mTOR inhibitors.
    Gyawali B; Shimokata T; Honda K; Kondoh C; Hayashi N; Yoshino Y; Sassa N; Nakano Y; Gotoh M; Ando Y
    Mol Clin Oncol; 2016 Nov; 5(5):641-646. PubMed ID: 27900103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?
    Deluche E; Lachatre D; Di Palma M; Simon H; Tissot V; Vansteene D; Meingan P; Mohebi A; Lenczner G; Pigneur F; Goldwasser F; Raynard B;
    Breast; 2022 Feb; 61():84-90. PubMed ID: 34923226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
    Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of skeletal muscle mass in patients with recurrent gastric cancer.
    Matsunaga T; Satio H; Miyauchi W; Shishido Y; Miyatani K; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
    World J Surg Oncol; 2021 Jun; 19(1):170. PubMed ID: 34116681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.